最新报道:According to Bijie.com, market data shows that Qualigen Therapeutics (QLGN) surged 340% in pre-market trading to $12.49. This follows news that Faraday Future ($FFAI.M) announced a strategic investment in Qualigen Therapeutics ($QLGN.M) through a $41 million PIPE transaction. The company will be renamed CXC10 and transition into a crypto and Web 3 platform. Upon completion of the transaction, Faraday Future and Jia Yueting will hold a combined approximately 62% stake in the company. Jia Yueting will serve as Chief Advisor, and FF President Jerry Wang will serve as Co-CEO.